Home > Insider Trading > Filing (0001062993-25-010396)

Filing Details

Accession Number:: 0001062993-25-010396
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-27 18:34:31
Reporting Period:: 2025-05-22

Filing Date:: 2025-05-27
Accepted Time:: 2025-05-27 18:34:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840877	Envoy Medical Inc.	COCH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1712459	Charles Brynelsen	C/O 4875 White Bear Parkway White Bear Lake MN 55110		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2025-05-22	2,000	$1.68	2,000	No	4	P	Direct
Class A Common Stock	Acquisiton	2025-05-23	13,000	$1.64	15,000	No	4	P	Direct
Class A Common Stock	Acquisiton	2025-05-27	35,000	$1.65	50,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Option (right to buy)	$2.40		2033-10-15	62,500	62,500	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2033-10-15	62,500	62,500	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6875 to $1.6794 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6333 to $1.6497 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6345 to $1.65 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Options to purchase 46,875 shares vest on 10/15/2023, and the remaining 15,625 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.